| Arnold D Gargantos, PHARMD | |
|
3586 Redondo Beach Blvd, Torrance, CA 90504-1404 | |
| (310) 370-1040 | |
| (310) 542-6411 |
| Full Name | Arnold D Gargantos |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3586 Redondo Beach Blvd, Torrance, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023227311 | NPI | - | NPPES |
| 43604 | Other | CA | REGISTERED PHARMACIST LIC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 43604 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Arnold D Gargantos, PHARMD 49 Eastfield Dr, Rolling Hills, CA 90274-5259 Ph: (310) 370-1040 | Arnold D Gargantos, PHARMD 3586 Redondo Beach Blvd, Torrance, CA 90504-1404 Ph: (310) 370-1040 |
News Archive
The Maryland Stem Cell Research Commission has completed its evaluation of the 141 applications in response to its three official Requests for Applications during the FY 2010 funding cycle. The board of directors of the Maryland Technology Development Corporation reviewed the Commission's recommendations and approved 42 projects totaling $11.7 million in funding through the Maryland Stem Cell Research Fund under the Maryland Stem Cell Research Act of 2006.
A study led by Robert N. Weinreb, chairman and Distinguished Professor of Ophthalmology at the University of California, San Diego School of Medicine, has received a $6.4 million, 5-year grant from the National Eye Institute, part of the National Institutes of Health, to elucidate the genetics of glaucoma in persons of African descent.
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.
In the trial of Dr Jayant Patel an expert surgeon who testified last week was cross examined by the defence lawyers. Patel is currently on trial in the Supreme Court in Brisbane for the manslaughter of three patients and causing grievous bodily harm to a fourth.
› Verified 5 days ago
Dr. Helen Haekyong Whang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3860 Sepulveda Blvd, Torrance, CA 90505 Phone: 310-373-5884 Fax: 310-373-9263 | |
Flora Amy Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4101 Torrance Blvd, Torrance, CA 90503 Phone: 310-540-7676 | |
Christine Gobran, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 Lomita Blvd, Torrance, CA 90505 Phone: 310-784-8713 | |
Dr. Ahmed Sadek Atallah, PHD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1327 El Prado Ave, Torrance, CA 90501 Phone: 310-328-7244 Fax: 310-782-3519 | |
Young Yoon Sung, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2800 Plaza Del Amo Unit 14, #14, Torrance, CA 90503 Phone: 310-619-4269 | |
Kristin Anne Dionisio Ignacio, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3640 Lomita Blvd Ste 106, Torrance, CA 90505 Phone: 310-784-8713 | |
Gordana Cutovic, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23600 Telo Ave Ste 150, Torrance, CA 90505 Phone: 424-250-1701 |